A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations: implications for peptide-based analgesics.
Sci Rep. 2019 Jan 30;9(1):930. doi: 10.1038/s41598-018-37585-5.
Sci Rep. 2019.
PMID: 30700786
Free PMC article.